Amar Kelkar

25PUBLICATIONS
151CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersGene and molecular therapyCardiovascular medicine and haematology not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (25)

|Apr 30, 2026
Randomized, Placebo-Controlled Trial of B-Cell Depletion for Prevention of Corticosteroid-Requiring Chronic Graft-Versus-Host Disease.

|Feb 25, 2026
WBC Growth Factors: ASCO Guideline Update.

Bishal Gyawali, Kari Bohlke, Jana K Dickter

|Jan 26, 2026
Baseline IPSS-M vs pretransplant risk downstaging as prognostic determinants in MDS undergoing allogeneic transplantation.

Luis E Aguirre, Haesook T Kim, Hany Elmariah

|Dec 05, 2025
Venetoclax/FluBu2 RIC transplant followed by all-oral venetoclax/decitabine maintenance for poor-risk MDS/AML.

Jacqueline S Garcia, Haesook T Kim, H Moses Murdock

|Oct 31, 2025
No clear benefit of cellular therapy consolidation for patients achieving remission after post-HCT AML relapse.

H Moses Murdock, Haesook T Kim, Katie Maurer

|Jul 30, 2025
Real-world outcomes of infections following tisagenlecleucel in patients with B-cell ALL: a CIBMTR analysis.

Hemalatha G Rangarajan, Prakash Satwani, Megan M Herr

Pageof 5

Frequent Collaborators

4 joint publications

Jacqueline S Garcia

4 joint publications

Haesook T Kim

4 joint publications

Corey S Cutler

3 joint publications

Eric S Winer